SCHEMBL5672385

SCHEMBL5672385

CC(C)(C)OC(=O)N1CC[C@@H](Oc2ccc(Cl)cn2)C1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 6/20 0.58
PIK3CD O00329 8/20 0.51
PIK3CA P42336 4/20 0.48
CACNB4 O00305 2/20 0.48
CACNA1A O00555 2/20 0.48
CACNA1G O43497 2/20 0.48
CACNG3 O60359 2/20 0.48
CACNA1F O60840 2/20 0.48
CACNA1H O95180 2/20 0.48
CACNB3 P54284 2/20 0.48
CACNA2D1 P54289 2/20 0.48
CACNG7 P62955 2/20 0.48
CACNA1B Q00975 2/20 0.48
CACNA1D Q01668 2/20 0.48
CACNB1 Q02641 2/20 0.48
CACNG1 Q06432 2/20 0.48
CACNB2 Q08289 2/20 0.48
CACNA1S Q13698 2/20 0.48
CACNA1C Q13936 2/20 0.48
CACNA1E Q15878 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5672367 1.00 GPR119 (0.58) GPR119PIK3CDPIK3CACACNB4CACNA1A
SCHEMBL5270529 0.93 GPR119 (0.51) GPR119PIK3CDPIK3CACACNB4CACNA1A
SCHEMBL2775134 0.93 GPR119 (0.66) GPR119CACNB4CACNA1ACACNA1GCACNG3
SCHEMBL21887083 0.87 GPR119 (0.59) GPR119PIK3CDPIK3CANPBWR1MCHR1
SCHEMBL26774179 0.87 GPR119 (0.59) GPR119PIK3CDPIK3CANPBWR1MCHR1
SCHEMBL20234855 0.87 GPR119 (0.59) GPR119PIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL26774174 0.87 GPR119 (0.59) GPR119PIK3CDPIK3CANPBWR1MCHR1
SCHEMBL3401880 0.86 GPR119 (0.58) GPR119PIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL18089521 0.86 GPR119 (0.58) GPR119PIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL22825652 0.86 GPR119 (0.58) GPR119PIK3CDPIK3CAPIK3CBPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7129243-B2 Peptide compounds ASTELLAS PHARMA INC. (JP) 2006-10-31 US disclosed
US-20040097425-A1 Peptide compounds ASTELLAS PHARMA INC. (JP) 2004-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040097425-A1 Peptide compounds VIP, NOS1, NOS3 GPR119 118/4885PIK3CD 4803/4885PIK3CA 4830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.